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dichroism  (CD),  electron paramagnetic  resonance  (EPR) and visible 
absorption  spectroscopy.  The  results  confirm  previous  findings  that 
VIVO2+ occupies at least two types of binding sites on albumin: ‘the 
strong vanadium binding  site’  (designated by VBS1)  and  ‘the weak 
vanadium  binding  sites’  (designated  by VBS2).  VBS1  binds  1 mol 
equivalent of VIVO2+. On the other hand VBS2 correspond to binding 
of several mol equivalents of VIVO, and studies done with PSA in the 







(VIVO)-HSA  system  by  the  type  and  intensity  of  the  CD  spectra 
recorded. Changes are also observable in the intensity of the X-band 
EPR  spectra,  but  not  much  in  the  hyperfine  coupling  constants Az, 
which  are  all  in  the  range  166-167 ×  10-4 cm-1. The  results  further 
demonstrate  that  the presence of maltol may enhance  the binding of 
VIVO to albumin.
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ternarias  de maltol  (maltol)m(VIVO)mHSA y  (maltol)2m(VIVO)mHSA 
de forma estequiométrica las cuales son claramente distinguibles del 











to  its  pharmacokinetic  properties.  The  studies  carried  out  to 
investigate the significance of vanadium as well its compounds 
in biological systems have led to the discovery of its potential 
as  a  therapeutic  agent.  Many  publications  illustrate  its  insu-
lin-mimetic [1, 2], anti-cancer [3-5], anti-parasitic [6, 7] anti-
microbial  [8,  9]  and  antispermicidal  [10]  actions.  VIVO  and 







it  may  undergo  transformations  in  the  gastrointestinal  tract, 




Notwithstanding, many  other  studies  have  shown  differences 
in activity between VIVO2+ administered as a  salt  (VIVOSO4) 
and  as VIVO(carrier)n  complexes  (examples  in Figure 1)  [17, 
18, 24, 26].
Albumin is the most abundant large globular protein in the 





and  PSA  are  similar;  however,  there  are  some  variations  in 
the number  and  sequence of  their  amino acids  [27]. Namely, 
HSA contains only one  [29]  tryptophan while both BSA and 
PSA  contain  two  [27]  each;  due  to  this  difference  the molar 












There  are  14  conserved  His  residues  in  human,  bovine 
and porcine albumins [31], but only three of them are located 
close enough to each other in space to provide a strong bind-
ing  site  for metal  ions. An  important  difference  between  the 
three albumins is the ATCUN motif: (i) HSA has Asp-1, Ala-
2,  and  His-3  at  the  N-terminus,  (ii)  BSA  has  Asp-1,  Thr-2 
and  His-3,  while  (iii)  PSA  has  His-3  substituted  by  Tyr-3. 
[27,  34] Other  groups  such  as  carboxylates  and  amides may 
also play  roles  in metal  ion binding  to  albumin.  It  is  consid-
ered  that  for  BSA  the  primary  binding  site  for  CuII  is  also 
the 3 residues of  its N-terminal site, while for PSA, although 
Cu-binding  would  be  possible,  data  indicate  it  is  elsewhere 
in  the  protein  [30].  The  positions  of  the CD bands  and EPR 
parameters  for  CuII  bound  at  the MBS  suggest  coordination 
and  tetragonal  binding  geometry,  and  globally  the  the  simi-
larity  of  the  several  spectroscopic  parameters  between  albu-
mins suggest that the MBS has been mostly conserved during 
evolution.
Several  studies  have  reported  the  binding  of  VIVO2+  to 





interactions  that  may  involve  carboxylate  or  imidazole  side 
chains of amino acid residues [38, 39], and Chasteen reported 
at least five non-specific interactions [39].













































further  study  this  system  to  clarify  the  type  of VIVO-maltol-
HSA species formed.
Scheme 1. Several of the reported insulin mimetic compounds {most 





































R = CH3-: BMOV
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Experimental
Materials and preparation of solutions
The  chemical  reagents  and  albumins  were  used  as  received 
from the supplier without further purification.
Millipore water was used  for  the preparation of  the  so-







Fatted  HSA  (A1653,  fHSA)  and  defatted  HSA  (A3782, 
dHSA),  defatted BSA  (A-7511,  dBSA),  fatted BSA  (A3675, 
fBSA)  and  fatted  PSA  (A1830,  fPSA)  were  purchased  from 
Sigma-Aldrich.  Maltol,  and  VIVOSO4  were  also  purchased 
form Sigma-Aldrich.
The molecular weight as well as the molar extinction coef-
ficients used  for  the determination of  albumin concentrations 
were: (1) 66.5 kDa; ε(278 nm) = 36850 M-1cm-1  for  fatted 
HSA and defatted HSA [46-49] (2) defatted BSA (66,430 Da; 
ε280 = 44,300 M-1cm-1); and (3) fatted PSA (67,900 Da; ε280 
= 45,600 M-1cm-1)  [22, 36, 48]. These values were obtained 
from  the  indicated  references  and  product  information  docu-
ments from Sigma.
Albumin solutions: The albumin solutions were prepared 










































To  facilitate  the  description  of  the  composition  of  each 
solution  we  will  often  describe  a  solution  that  contains  e.g. 
HSA and CuII  in a 1:2 molar  ratio by Cu2HSA, or a solution 
with BSA and VIVO  in a 1:4 molar  ratio by  (VIVO)4BSA.  In 
some occasions  a  similar  designation will  be  used  to  specify 
a particular metal complex species. The designation VIVO2+ is 
used when referring to the VIVO(H2O)52+ or VIVO2+ as cations; 
the designation VIVO  is used when  referring  to  this unit  in  a 
complex species, e.g. (VIVO)4BSA.
Results and discussions








at λ < 520 nm.
Below 1 mol equivalent of VIVO2+ the CD signals are very 
low (Figure 1). This applies to both defatted and fatted HSA-





manifested  in  the  CD  spectrum  in  the  visible  range  when  it 
is  coordinated  by  donor  atoms  where  chirality  is  effectively 
transferred  from  the chiral centres of  the protein  to  the VIVO 
centre [51-57]. Binding to donor groups of amino acid residues 
of albumin may thus result  in the manifestation of d-d transi-
tions  in  the  visible  CD  spectrum  [22,  31,  37].  Considering 
the many  possible  binding  sites  of VIVO2+  on  albumin,  each 
mol equivalent of VIVO2+ may produce a visible CD spectrum 





The  zinc  primary  binding  site  (the  MBS  site)  is  at  the 
interface of domains I and II of HSA. In the presence of fatty 
acids  this site  is disrupted, and  the bound ZnII at  this site de-
creases drastically in the presence of long chain fatty acids. This 
disruption  is  caused by a domain-domain movement  that  can 
be described as a rotation of domain I with respect to domain 
II [29-32]. As a general remark to the spectra of Figure 1 we 
may  emphasize  that  the CD  spectra measured with  solutions 
containing dHSA and VIVO2+ are more intense than those with 




Figure 2  shows  the changes  in  the visible CD spectra of 
titration of fHSA with 0.8-8.9 mol equivalents of VIVO2+. The 
measured CD spectra are the result of the sum of all CD bands 
present,  some  with  ∆ε  >  0,  others  with  ∆ε < 0, due to the 
several  chiral  VIVO-complexes  being  formed.  Therefore  the 









one  is  considered  non-specific. Our  group  recently  discussed 
metal competition studies of Cu(II) and Zn(II) as metal probes 
for  VIVO2+ binding with HSA  [37].  These  studies  confirmed 
the involvement of amino acid side chains of the ATCUN and 
MBS sites.  In  this work we also examine  the metal competi-
tion studies of Cu(II) and Zn(II) as metal probes with VIVO2+ 
binding with BSA and PSA.
Studies with defatted BSA and VIVO2+
BSA,  like  HSA,  was  reported  to  have  two  binding  sites  for 
metals. One site is the MBS which is the principal binding site, 
while  the  second  site  is  the  site B or Cd2+ primary  site  [30]. 
The CD spectra in the visible range observed after titrating 0.45 
mM of BSA (defatted) with increasing mol equivalents (0.6 to 











Yasui  et al.  [34]  also  observed  positive  CD  with  λmax 








































than  0.05  M-1cm-1  at  both  bands.  The  mol  equivalents  of  VIVO2+ 





























The  EPR  spectra  shown  in  Figure  4  indicate  that  some 
VIVO2+ remained bound to dBSA when ZnII was added; in fact 
the VIVO EPR  signals  are  still  observable  after  addition of  3 
mol  equivalents  of ZnII. Only  one  type  of  signal  is  observed 
in  the  three  spectra,  but  the  peaks  decrease  in  intensity with 
the amount of ZnII added. At pH 7.4 the VIVO2+ displaced by 








Studies with fatted PSA and VIVO2+
Further  studies  to  determine  the  binding  site  on  HSA  were 
carried out with fatted PSA. PSA lacks His-3 residue which is 
required  for  the  formation of  the ATCUN motif,  the primary 
binding  site  of  CuII  on HSA  and BSA. As  stated  above  and 
in  the SI section, PSA differs  from HSA and BSA in several 
aspects,  namely  the  substitution  of His-3  by Tyr-3. Thus  the 
N-terminal strong CuII and NiII binding site (ATCUN) does not 









(VIVO:PSA), two isodichroic points being observed: (i) at λ ≈ 
638 nm and Δε ≈ -0.0074 M-1cm-1 and (ii) at λ = ~ 760 nm and 
Δε ≈ -0.013 M-1cm-1. The second type of CD spectra involves 
at least two species: one forming up to 1:3 (VIVO:PSA) with a 
λmax at ≈525 nm and Δε ≈ -0.07 M-1cm-1, and the remaining 
one at higher mol amounts of VIVO2+ (Figure 5), with increase 
of the |Δε| values of the bands at λ ≈ 580 and 700 nm, decrease 
of the |Δε| values at ≈525 nm and shift  to  the red of  the λmax 
of the band at ca. 850-900 nm. At least two isodichroic points 
are visible: (i) at λ = ~ 658 nm and Δε = ~ -0.07 M-1cm-1; and 
(ii) at λ ≈ 680 nm and Δε ≈ -0.08 M-1cm-1.
Upon addition of 1 - 2 mol equivalents of ZnII  to a solu-




The  (VIVO)mPSA  (m  =  1,2,6)  EPR  spectra  depicted  in 
Figure 7 show that  the resonant field positions of all samples 





















































































Bal  et al.  [31]  reported  that  titration  of  0.67  mM  PSA 
solution with CuII  ions  at  pH 7.4  yielded only  ‘one’  positive 
















multiplier,  thus allowing  recording  the CD signal up  to 1000 
Fig. 5.  CD  spectra  of  a  0.63 mM  solution  of  fPSA  (fatted)  in HE-
PES-S buffer (pH = 7.4) and upon successive additions of 1 to 6 mol 
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Fig. 7.  First  derivative X-band EPR  spectra  of  frozen  solutions  (77 














186      J. Mex. Chem. Soc. 2013, 57(3)  Enoch Cobbina et al.
nm. When 0.60 mM fPSA was titrated with 0.5 to 5 mol equiva-
lents of VIVO2+, four bands were observed in the 500-1000 nm 
region, Figure 8. The bands have λmax at ~525 nm (Δε < 0), 



















The decrease  in  intensity of  the CD band due  to  the Cu-
PSA  species  as  VIVO2+  is  added  indicates  the  displacement 
of  CuII  from  the MBS  site  of  PSA.  Also  there  is  a  shift  in 
the λmax  from 650 nm  to ~690 nm as new species  form,  this 
































(VIVO)mHSA interaction with maltol
To  gain more  insight  into  the  possible  interaction  of VIVO2+ 




When  0.67 mM  (VIVO)0.9HSA  (fatted) was  titrated with 
0.2-2.6  mole  equivalents  of  maltol,  the  CD  spectra  depicted 
in  Figure  11a were  obtained. Very  clear  changes  are  seen  in 
the CD spectra  in  the visible  region upon addition of maltol, 
particularly  in  the  650-1000  nm  range,  but  changes  are  also 






Fig. 8. Comparison of  the  spectra of  solutions containing  fPSA and 
either CuII or VIVO. (──): fPSA and VIVO with fPSA:M molar ratio 
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of VIVO2+ added  to HSA,  there may be several  (VIVO)mHSA 
(m > 1) species available to interact with maltol, and at higher 
ratios  of VIVO:HSA  there will  be  a  higher  number  of VIVO-
centres available to interact with maltol,  thus producing more 
intense CD spectra in the visible region. The system containing 
e.g.  1:3.5:10.5  (HSA:VIVO:maltol)  will  therefore  have  more 
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and 12, namely  the relative  intensity of  the bands at 530-590 
nm and 750-800 nm, show the formation of at least two types 
of chiral species: (1) when the ratio of maltol:VIVO2+ < 1, and 
(2) when it is >1. In Figure 11b an isodichroic point is observed 
at λ ≈ 507 nm, Δε ≈ -0.025 M-1cm-1 suggesting the existence 
of two distinct types of chiral species in equilibrium when the 








the maltol:VIVO2+ ratio is <1 and when maltol:VIVO2+ ratio is 
≥1; (3) Increasing concentration of maltol increased the inten-
sity of the negative bands up to ~11 (band at ~570 nm) or ~14 
mol equivalents (band at ~780 nm) of maltol; (4) The observed 
changes  in  the  (VIVO)mHSA  spectra  upon  addition  of maltol 
suggests  that  maltol  interacts  with  the  VIVO-centers  bound 




the  CD  and  EPR  spectra  are  compatible  with  the  formation 
of  at  least  two  sets  of  species  (possibly  three) when HSA  is 
titrated with VIVO2+. Moreover, the oligomeric forms of VIVO 
formed at VBS1, and possibly also at other sites are not easily 





sitions  do  not  change  suggesting  that  the  VIVO-maltol-HSA 
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and gz = 1.940. Comparing the EPR parameters in Table 2 we 
may state  that  in  the  solutions  studied  the amount of BMOV 
formed,  in  any,  is  small.  Thus,  the  possible  stoichiometry 
of  the  species  that  may  form  are  (maltol)m(VIVO)mHSA  and 
(maltol)2m(VIVO)mHSA.








N-imidazole  atoms  of  His  residues.  Our  results  indicate  that 




ratio) bound  to HSA  is  indicated by  the change of pattern of 
the CD spectra as maltol  is added  to  the solutions containing 
VIVO2+ and HSA.













Reviewing  the  study  of  the  interaction  of  VIVO  with  HSA, 
including the use of EPR and CD spectra, as well as metal com-
petition studies with CuII and ZnII as metal probes, the results 
confirmed  that  at  least  two  types of binding  sites  are present 















site)  in  the  presence  of  an  excess  of ZnII  indicates  that  a  3rd 
type of  site  is  present  in PSA but  probably  also  in HSA and 
BSA.
The EPR and CD studies carried out with the HSA-VIVO-











Network  (IST-UTL  Center)  and  PEst-OE/QUI/UI0100/2011, 




TJ  thanks  for  the  János  Bolyai  Research  Scholarship  of  the 
Hungarian Academy of Sciences.



















190      J. Mex. Chem. Soc. 2013, 57(3)  Enoch Cobbina et al.
References
  1. Liboiron, B. D.; Thompson, K. H.; Hanson, G. R.; Lam, E.; Aebi-
scher, N.; Orvig, C. J. Am. Chem. Soc. 2005, 127, 5104-5115.
  2. Rehder,  D.  Bioinorganic Vanadium Chemistry;  John  Wiley  & 
Sons, Ltd: England, 2008.








  6. Benítez,  J.;  Guggeri,  L.;  Tomaz,  I.;  Costa  Pessoa,  J.;  Moreno, 
V.; Lorenzo,  J.; Avilés, F. X.; Garat, B.; Gambino, D. J. Inorg. 
Biochem. 2009, 103, 1386-1394.
  7. Maurya, M. R.; Khan, A. A.; Azam, A.; Kumar, A.; Ranjan, S.; 




  9. Maiti, A.; Ghosh, S. J. Inorg. Biochem. 1989, 36, 131-139.
 10. Ghosh, P.; D’Cruz, O. J.; DuMez, D. D.; Peitersen, J.; Uckun, F. 
M. J. Inorg. Biochem. 1999, 75, 135-143.



























 23. Thompson, K. H.; Orvig, C. Coord. Chem. Rev. 2001, 1033, 219-
221.









 28. Murray,  R.  K.;  Granner,  D.  K.; Mayes,  P.  A.;  Rodwell,  V. W. 
Harper’s Illustrated Biochemistry; 26th ed.; McGraw-Hill USA, 
2003.







D. P Natl. Acad. Sci. USA 2003, 100, 3701-3706.
 33. Christodoulou, J.; Sadler, P. J.; Tucker, A. Eur. J. Biochem. 1994, 
225, 363-368.
 34. Yasui, H.; Kunori, Y.;  Sakurai, H. Chem. Lett. 2003, 32,  1032-
1033.









 39. Chasteen,  N.  D.;  Francavilla,  J.  J. Phys. Chem.  1976,  80,  867-
871.
 40. Costa Pessoa, J.; Luz, S. M.; Gillard, R. D. J. Chem. Soc. Dalton 
Trans. 1997, 569-576.
 41. Costa Pessoa, J.; Gagja, T.; Gillard, R. D.; Kiss, T.; Luz, S. M.; 








 45. Costa  Pessoa,  J.;  Tomaz,  I.;  Kiss,  T.;  Kiss,  Buglyó,  P.  J. Biol. 
Inorg. Chem. 2002, 7, 225-240.
 46. Hirayama,  K.;  Akashi,  S.;  Furuya,  M.;  Fukuhara,  K.  Biochem. 
Bioph. Res. Co. 1990, 173, 639-646.









 51. Costa  Pessoa,  J.;  Correia,  I.;  Gonçalves,  G.;  Tomaz,   I. 
















 60. Chasteen, N.D.;  in Biological Magnetic Resonance (Ed.: J. Reu-
ben), Plenum, New York, 1981, p. 53-119.
Binding of Oxovanadium(IV) Complexes to Blood Serum Albumins  191







420 520 620 720 820 920λ / nm









Fig. SI-4 (old 14).  The X-band EPR  frozen  solution  spectra  (at  77 
K)  of  Cu2PSA  recorded  in  the  presence  of  2  (1:2:2)  and  5  (1:2:5) 







Fig. SI-1 (old Fig. 4). CD spectra of titration of solutions containing 
0.5 mM dBSA, VIVOSO4 and ZnCl2 solution. The defatted BSA was 
first loaded with ~4 mol equivalents of VIVO2+. The mol equivalents 


















Fig. SI-2 (old 8). CD spectra of a 0.63 mM solution of fPSA (fatted) 
in HEPES-S buffer (pH = 7.4) and upon additions of 6 mol equivalents 
of VIVO2+, followed by additions of a 56 mM ZnCl2 solution. The mol 
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